1-18 of 18
Bruce C. Bostrom
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Comparison of self-report and electronic monitoring of 6MP intake in childhood ALL: a Children’s Oncology Group study

Clinical Trials & Observations
Wendy Landier, Yanjun Chen, Lindsey Hageman, Heeyoung Kim, Bruce C. Bostrom, Jacqueline N. Casillas, David S. Dickens, William E. Evans, Kelly W. Maloney, Leo Mascarenhas, A. Kim Ritchey, Amanda M. Termuhlen, William L. Carroll, Mary V. Relling, F. Lennie Wong, Smita Bhatia
Journal: Blood
Blood (2017) 129 (14): 1919–1926.
https://doi.org/10.1182/blood-2016-07-726893
Published: 2017
Includes: Supplemental data
Journal Articles

6-Mercaptopurine (6MP) Intake during Maintenance for Childhood Acute Lymphoblastic Leukemia (ALL) - a Comparison of Self-Report and Electronic Monitoring: A Report from the Children's Oncology Group (COG) Study AALL03N1

Wendy Landier, PhD CRNP, Yanjun Chen, MS, Lindsey Hageman, MPH, Heeyoung Kim, MS, Bruce C. Bostrom, MD, Jacqueline Casillas, MD, M.S.H.S., David Dickens, MD, William E. Evans, PharmD, Kelly W. Maloney, MD, Leo Mascarenhas, MD MS, Arthur K. Ritchey, MD, Amanda M. Termuhlen, MD, William L. Carroll, MD, F. Lennie Wong, Mary V. Relling, PharmD, Smita Bhatia, MD MPH
Journal: Blood
Blood (2015) 126 (23): 82.
https://doi.org/10.1182/blood.V126.23.82.82
Published: 2015
Journal Articles

Impact of 6 Mercaptopurine (6MP) Pill-Taking Habits on Adherence, Thioguanine Nucleotide (TGN) Levels and Relapse Risk in Children with Acute Lymphoblastic Leukemia (ALL): Results from a Children’s Oncology Group (COG) Study (AALL03N1)

Lindsey Hageman, Wendy Landier, PhD, R.N., Yanjun Chen, MS, Heeyoung Kim, M.S., Nancy Kornegay, M.S., William E. Evans, PharmD, Bruce C. Bostrom, MD, Jacqueline Casillas, MD, M.S.H.S., David Dickens, MD, Anne Angiolillo, MD, Glen Lew, MD, Kelly Maloney, MD, Leo Mascarenhas, Arthur K. Ritchey, MD, Amanda Termuhlen, MD, William L. Carroll, MD, Mary V. Relling, PharmD, F. Lennie Wong, Smita Bhatia, PhD
Journal: Blood
Blood (2014) 124 (21): 369.
https://doi.org/10.1182/blood.V124.21.369.369
Published: 2014
Journal Articles

A Phase I Dose Finding Study of Panobinostat in Children with Hematologic Malignancies: Initial Report of TACL Study T2009-012 in Children with Acute Leukemia

John M Goldberg, MD, Julia Glade-Bender, MD, Maria Luisa Sulis, MD, Rebecca A Gardner, MD, Jessica A. Pollard, MD, Victor Aquino, MD, Naomi J. Winick, MD, Bruce C. Bostrom, MD, Cecilia Fu, MD, Raymond J. Hutchinson, MD, Thomas J. Manley, MD, Rajen Mody, MD MS, Javier Oesterheld, MD, Blythe Thomson, MD, Julie R Park, MD, Jeannette Cassar, Elena Eckroth, CCRC, Richard Sposto, PhD, Yoav H Messinger, MD, Nobuko HiJiya, MD, Paul S Gaynon, MD, Julio C. Barredo, MD
Journal: Blood
Blood (2014) 124 (21): 3705.
https://doi.org/10.1182/blood.V124.21.3705.3705
Published: 2014
Journal Articles

High Intra-Individual Variability In Systemic Exposure To 6 Mercaptopurine (6MP) In Children With Acute Lymphoblastic Leukemia (ALL) Contributes To ALL Relapse: Results From a Children’s Oncology Group (COG) Study (AALL03N1)

Smita Bhatia, Ph.D., Wendy Landier, Ph.D., R.N., Lindsey Hageman, Can-Lan Sun, Heeyoung Kim, M.S., Nancy Kornegay, M.S., William E. Evans, PharmD, Bruce C. Bostrom, MD, Jacqueline Casillas, M.D., M.S.H.S, Anne Angiolillo, MD, Glen Lew, MD, Kelly Maloney, MD, Leo Mascarenhas, Jane Meza, Ph.D., A. Kim Ritchey, MD, Amanda Termuhlen, MD, William L. Carroll, MD, F. Lennie Wong, PhD, Mary V. Relling, PharmD
Journal: Blood
Blood (2013) 122 (21): 59.
https://doi.org/10.1182/blood.V122.21.59.59
Published: 2013
Journal Articles

Nonadherence to Oral 6-Mercaptopurine (6MP) in a Multi-Ethnic Cohort of Children with Acute Lymphoblastic Leukemia (ALL) and Its Impact On Relapse – a Children's Oncology Group (COG) Study (AALL03N1)

Smita Bhatia, MD, MPH, Wendy Landier, Ph.D., R.N., Lindsey Hageman, M.P.H., Heeyoung Kim, M.S., Cara Hanby, B.S., Kornegay Nancy, M.S., Bruce C. Bostrom, MD, Jacqueline Casillas, M.D., M.S.H.S., David S Dickens, M.D., Kelly W. Maloney, MD, Leo Mascarenhas, Jane Meza, Ph.D., Arthur Kim Ritchey, MD, Amanda M Termuhlen, M.D., William L. Carroll, MD, F. Lennie Wong, PhD, Mary V. Relling, PharmD
Journal: Blood
Blood (2012) 120 (21): 882.
https://doi.org/10.1182/blood.V120.21.882.882
Published: 2012
Journal Articles

Bortezomib with chemotherapy is highly active in advanced B-precursor acute lymphoblastic leukemia: Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Study

Clinical Trials & Observations
Yoav H. Messinger, Paul S. Gaynon, Richard Sposto, Jeannette van der Giessen, Elena Eckroth, Jemily Malvar, Bruce C. Bostrom
Journal: Blood
Blood (2012) 120 (2): 285–290.
https://doi.org/10.1182/blood-2012-04-418640
Published: 2012
Includes: Supplemental data
Journal Articles

Bortezomib Combined with VXLD Chemotherapy Is Highly Effective In Advanced B-Lineage Acute Lymphoblastic Leukemia Allowing Early Study Termination Due to Efficacy. A Therapeutic Advances in Childhood Leukemia (TACL) Consortium Phase II Study

Yoav H Messinger, MD, Paul Gaynon, MD, Richard Sposto, Ph.D., Jeannette van der Giessen, BA, CCRP, Elena Eckroth, CCRC, Jemily Malvar, M.S., Bruce C. Bostrom, MD
Journal: Blood
Blood (2011) 118 (21): 251.
https://doi.org/10.1182/blood.V118.21.251.251
Published: 2011
Journal Articles

Escalating intravenous methotrexate improves event-free survival in children with standard-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group

Clinical Trials & Observations
Yousif Matloub, Bruce C. Bostrom, Stephen P. Hunger, Linda C. Stork, Anne Angiolillo, Harland Sather, Mei La, Julie M. Gastier-Foster, Nyla A. Heerema, Scott Sailer, Patrick J. Buckley, Blythe Thomson, Catherine Cole, James B. Nachman, Gregory Reaman, Naomi Winick, William L. Carroll, Meenakshi Devidas, Paul S. Gaynon
Journal: Blood
Blood (2011) 118 (2): 243–251.
https://doi.org/10.1182/blood-2010-12-322909
Published: 2011
Journal Articles

Children with Down Syndrome (DS) and NCI Standard Risk (SR) Acute Lymphoblastic Leukemia (ALL) Have a Superior Five-Year Event-Free Survival (EFS) When Treated with Escalating Intravenous Methotrexate on the Children's Cancer Group (CCG) Study 1991

Yousif Matloub, MD, Bruce C. Bostrom, MD, Stephen Hunger, MD, Anne Angiolillo, MD, Meenakshi Devidas, PhD, Mei La, Nyla A. Heerema, Ph.D., Naomi Winick, MD, James Nachman, MD, Harland Sather, PhD, William L. Carroll, MD, Paul S Gaynon, MD
Journal: Blood
Blood (2010) 116 (21): 497.
https://doi.org/10.1182/blood.V116.21.497.497
Published: 2010
Journal Articles

Children with NCI Standard Risk Acute Lymphoblastic Leukemia (ALL) and TEL-AML1 or Favorable Chromosome Trisomies Are Almost Certain to Be Cured with Graduated Intensity Therapy: Results of the CCG - 1991 Study.

Yousif Matloub, MD, Bruce C. Bostrom, MD, Anne L Angiolillo, MD, Meenakshi Devidas, PhD, Nyla A. Heerema, PhD, Julie M. Gastier-Foster, PhD, Stephen P Hunger, MD, Harland Sather, PhD, Stephen Linda, William L. Carroll, MD, James B Nachman, MD, Paul S. Gaynon, MD
Journal: Blood
Blood (2009) 114 (22): 320.
https://doi.org/10.1182/blood.V114.22.320.320
Published: 2009
Journal Articles

Escalating Dose Intravenous Methotrexate without Leucovorin Rescue during Interim Maintenance Is Superior to Oral Methotrexate for Children with Standard Risk Acute Lymphoblastic Leukemia (SR-ALL): Children’s Oncology Group Study 1991

Yousif Matloub, MD, Bruce C. Bostrom, MD, Stephen P. Hunger, MD, Anne L Angiolillo, MD, Catherine Cole, MD, Blythe Thomson, MD, Meenakshi Devidas, PhD, Nyla A. Heerema, PhD, Mei K La, Patrick J. Buckley, MD, PhD, William L. Carroll, MD, Naomi Winick, MD, Harland Sather, PhD, James B Nachman, MD, Paul S. Gaynon, MD
Journal: Blood
Blood (2008) 112 (11): 9.
https://doi.org/10.1182/blood.V112.11.9.9
Published: 2008
Journal Articles

Bone Marrow (BM) Minimal Residual Disease (MRD) at End of Induction and Interim Maintenance Is Highly Predictive of Outcome in Children with Standard Risk (SR) Acute Lymphoblastic Leukemia (ALL) Treated on the Children’s Oncology Group Study 1991

Yousif Matloub, MD, Paul S. Gaynon, MD, Somasundaram Jayabose, MD, Bruce C. Bostrom, MD, Stephen P. Hunger, MD, Anne L Angiolillo, MD, Meenakshi Devidas, PhD, Stephen Linda, William L. Carroll, MD, Naomi Winick, MD, Harland Sather, PhD, Sharon R Pine, PhD
Journal: Blood
Blood (2008) 112 (11): 701.
https://doi.org/10.1182/blood.V112.11.701.701
Published: 2008
Journal Articles

Remarkable Activity of Bortezomib Combined with Chemotherapy in a Phase I Study of Relapsed Childhood Acute Lymphoblastic Leukemia (ALL). A Report from the Therapeutic Advances in Childhood Leukemia (TACL) Consortium.

Yoav H. Messinger, MD, Paul S. Gaynon, MD, Elizabeth Raetz, MD, Raymond Hutchinson, MD, MS, Steven DuBois, MD, Julia Glade Bender, MD, Richard Sposto, PhD, Jeannette van der Giessen, BA, CCRP, Elena Eckroth, CCRC, Bruce C. Bostrom, MD
Journal: Blood
Blood (2008) 112 (11): 1919.
https://doi.org/10.1182/blood.V112.11.1919.1919
Published: 2008
Journal Articles

Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group

Clinical Trials & Observations
Bruce C. Bostrom, Martha R. Sensel, Harland N. Sather, Paul S. Gaynon, Mei K. La, Katherine Johnston, Gary R. Erdmann, Stuart Gold, Nyla A. Heerema, Raymond J. Hutchinson, Arthur J. Provisor, Michael E. Trigg
Journal: Blood
Blood (2003) 101 (10): 3809–3817.
https://doi.org/10.1182/blood-2002-08-2454
Published: 2003
Journal Articles

A randomized comparison of native Escherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: a Children's Cancer Group study

Clinical Trials & Observations
Vassilios I. Avramis, Susan Sencer, Antonia P. Periclou, Harland Sather, Bruce C. Bostrom, Lewis J. Cohen, Alice G. Ettinger, Lawrence J. Ettinger, Janet Franklin, Paul S. Gaynon, Joanne M. Hilden, Beverly Lange, Fataneh Majlessipour, Pracad Mathew, Michael Needle, Joseph Neglia, Gregory Reaman, John S. Holcenberg
Journal: Blood
Blood (2002) 99 (6): 1986–1994.
https://doi.org/10.1182/blood.V99.6.1986
Published: 2002
Journal Articles

Double-delayed intensification improves event-free survival for children with intermediate-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group

Clinical Trials & Observations
Beverly J. Lange, Bruce C. Bostrom, Joel M. Cherlow, Martha G. Sensel, Mei K. L. La, Wayne Rackoff, Nyla A. Heerema, Robert S. Wimmer, Michael E. Trigg, Harland N. Sather
Journal: Blood
Blood (2002) 99 (3): 825–833.
https://doi.org/10.1182/blood.V99.3.825
Published: 2002
Journal Articles

Association of Chromosome Arm 9p Abnormalities With Adverse Risk in Childhood Acute Lymphoblastic Leukemia: A Report From the Children’s Cancer Group

Nyla A. Heerema, Harland N. Sather, Martha G. Sensel, Wen Liu-Mares, Beverly J. Lange, Bruce C. Bostrom, James B. Nachman, Peter G. Steinherz, Raymond Hutchinson, Paul S. Gaynon, Diane C. Arthur, Fatih M. Uckun
Journal: Blood
Blood (1999) 94 (5): 1537–1544.
https://doi.org/10.1182/blood.V94.5.1537
Published: 1999